10 authorised products containing Sitagliptin phosphate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Efficib 50 mg/1000 mg film-coated tablets EU/1/08/457/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Efficib 50 mg/850 mg film-coated tablets EU/1/08/457/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV, | — |
| Janumet 50 mg/1000 mg film-coated tablets EU/1/08/455/008-014 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Janumet 50 mg/850 mg film-coated tablets EU/1/08/455/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV, | — |
| Ristfor 50 mg/1000 mg film-coated tablets EU/1/10/620/009-016 |
Metformin Hydrochloride, Sitagliptin phosphate | Merck Sharp & Dohme BV, | — |
| Ristfor 50 mg/850 mg film-coated tablets EU/1/10/620/1-8 |
Metformin Hydrochloride, Sitagliptin phosphate | Merck Sharp & Dohme BV | — |
| Sitagliptin and Metformin hydrochloride Ascend 50 mg/1000 mg film-coated tablets PA23429/002/002 |
Sitagliptin phosphate, Metformin Hydrochloride | Ascend GmbH | Not marketed |
| Sitagliptin and Metformin hydrochloride Ascend 50 mg/850 mg film-coated tablets PA23429/002/001 |
Sitagliptin phosphate, Metformin Hydrochloride | Ascend GmbH | Not marketed |
| Velmetia 50 mg/1000 mg film-coated tablets EU/1/08/456/8-14 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV | — |
| Velmetia 50 mg/850 mg film-coated tablets EU/1/08/456/1-7 |
Sitagliptin phosphate, Metformin Hydrochloride | Merck Sharp & Dohme BV, | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.